Table 3.
Variables | Adherence level |
Crude | Adjusted | |
---|---|---|---|---|
Good | Poor | |||
Health facility | ||||
Health center | 114 (93.4) | 8 (6.6) | 1.00 | 1.00 |
Hospital | 53 (77.9) | 15 (22.1) | 0.25 (0.10, 0.60) | 0.30 (0.11, 0.80)* |
Age (yr) | ||||
≤29 | 94 (89.5) | 11 (10.5) | 1.00 | 1.00 |
>30 | 73 (85.9) | 12 (14.1) | 0.71 (0.29, 1.71) | 0.95 (0.33, 2.76) |
Place of residence | ||||
Rural | 31 (75.6) | 10 (24.4) | 0.29 (0.12, 0.74) | 0.26 (0.09, 0.73)* |
Urban | 136 (91.3) | 13 (8.7) | 1.00 | 1.00 |
Marital status | ||||
Cohabitating | 31 (79.5) | 8 (20.5) | 1.00 | 1.00 |
Married | 136 (90.1) | 15 (9.9) | 2.34 (0.91, 6.00) | 1.31 (0.43, 3.93) |
Educational level | ||||
No formal education | 35 (83.3) | 7 (16.7) | 1.00 | 1.00 |
Formal education | 132 (89.2) | 16 (10.8) | 1.65 (0.63, 4.32) | 1.63 (0.47, 5.56) |
Challenges faced in same-day diagnosis and initiating option B+ treatment | ||||
Yes | 73 (77.7) | 21 (22.3) | 0.07 (0.02, 0.33) | 0.08 (0.02, 0.37)* |
No | 94 (97.9) | 2 (2.1) | 1.00 | 1.00 |
Experienced any ARV side effects | ||||
Yes | 91 (81.3) | 21 (18.8) | 1.00 | 1.00 |
No | 76 (97.4) | 2 (2.6) | 8.77 (1.20, 38.60) | 3.26 (0.65, 16.36) |
Values are presented as frequency (%) or odds ratio (95% confidence interval).
PMTCT, prevention of mother-to-child transmission; HIV, human immunodeficiency virus; ARV, antiretroviral.
p<0.05.